← brief for 2026-11-03 · Slowing decline

Urinary Volatile Organic Compounds as Pharmacodynamic Biomarkers in Sodium-glucose Cotransporter 2 Inhibitor-treated Diabetic Kidney Disease.

Paper No results yet Peer reviewed

Key takeaways

This is a review article that discusses how a certain diabetes drug works in the body. It looks at how the drug changes chemicals in the urine. It explains the science behind the drug's kidney-protecting effects. There are no new results from a specific experiment in this piece.

Who did this work

Mathew GG · Ramanathan G

Source

Paper · PubMed, the drug frontier · 2026 Nov 2
https://pubmed.ncbi.nlm.nih.gov/42975214/